Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI

Published:2016-11-11 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ali Ahmed Atef Ahmed,Hsu Fei-Ting,Hsieh Chia-Ling,Shiau Chia-Yang,Chiang Chiao-Hsi,Wei Zung-Hang,Chen Cheng-Yu,Huang Hsu-Shan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep36650.pdf

Reference53 articles.

1. Qin, X. et al. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors. Bioorg. Med. Chem. Lett. 26, 1571–1575 (2016).

2. Dienstmann, R., De Dosso, S., Felip, E. & Tabernero, J. Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer. Mol. Oncol. 6, 15–26 (2012).

3. Tu, Y. et al. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors. Bioorg. Med. Chem. 24, 1495–1503 (2016).

4. Herbst, R. S. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol., Biol., Phys. 59, 21–26 (2004).

5. Sette, G. et al. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer. Cell Death Dis. 6, e1850 (2015).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26

2. Biological Activity of Lactic Acid Bacteria Exopolysaccharides and Their Applications in the Food and Pharmaceutical Industries;Foods;2024-05-23

3. Advances in erlotinib delivery systems: Addressing challenges and exploring opportunities in EGFR-targeted cancer therapies;Inorganic Chemistry Communications;2024-03

4. New anthraquinone drugs and their anticancer activities: Cytotoxicity, DFT, docking and ADMET properties;Results in Chemistry;2023-12

5. Recent trends and advances in nanosystems with tyrosine kinase inhibitors for image-guided cancer treatments;Journal of Drug Delivery Science and Technology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3